Neptune

Lilly wards off another Alimta patent challenge, this time through IPR
Fierce Pharma
Fri, 10/6/17 - 11:42 am
Eli Lilly
Alimta
patents
IPR
lung cancer
Neptune
generics
Novartis
Sandoz
Stryker Recalls Neptune Devices After Death Reported
Tue, 09/25/12 - 09:13 pm
Stryker
Neptune
recall
safety
Whether Neptune Can Overcome Market Weigh-Down And Deliver On Milestones
Seeking Alpha
Wed, 09/28/11 - 11:45 am
Neptune
China
2 Emerging Biotech Companies That Continue to Attract Attention
Seeking ALpha
Mon, 05/23/11 - 11:46 am
Neptune
Dendreon
Northwest Biotherapeutics